Anna Alonso Saladrigues
Anna Alonso Saladrigues graduated in Medicine in 2008 at the Universitat Autònoma de Barcelona and she obtained a specialty in Pediatrics and Specific Areas in 2013 at the Universitat de Barcelona. In 2013, she finished the Master's Degree in Pediatric Hematology at the Universitat de Barcelona. She obtained the Postgraduate Master's Degree in "Research Methodology: Design and Statistics in Health Sciences" at the Universitat Autònoma de Barcelona in 2018.
She has focused her professional career in the field of hematology oncology and for the past 6 years she has been an assistant doctor at the Leukemia, Lymphoma and Histiocytosis Unit and a reference doctor at the CAR-T Unit of Hospital Sant Joan de Déu Barcelona since her creation.
Regarding therapeutic advances, she actively participates as a co-investigator in all clinical trials of CAR-T therapy at Hospital San Juan de Dios Barcelona, in clinical trials of hematology oncology, as well as in studies subsidized by official bodies.
Her postgraduate degree in applied statistics in health sciences has enabled her to perform the work of data manager of the unit and collaborate in the statistical analysis of the national database of the SEHOP (Sociedad Española de Hematología y Oncología Pediátrica).
- Ortiz-Maldonado V, Alonso-Saladrigues A, Español-Rego M, Martínez-Cibrián N, Anna Faura Faura, Magnano L, Català-Temprano A, Benítez-Ribas D, Giné E, Díaz-Beyá M, Correa JG, Rovira M, Montoro-Lorite M, Martínez-Roca A, Rodríguez-Lobato LG, Cabezón R, Cid J, Lozano M, Garcia-Rey E, Conde Cuevas N, Pedrals G, Rozman M, Torrebadell-Burriel M, Setoain X, Rodríguez S, Esteve J, Pascal M, Urbano-Ispizua Á, Juan-Otero M, Delgado J and Rives-Solà S Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease. AMERICAN JOURNAL OF HEMATOLOGY . 97(6): 731-739.
- Marina Caballero Bellón, Anna Faura Faura, Margarit A, Bobillo-Perez S, Català-Temprano A, Alonso-Saladrigues A, Conde Cuevas N, Balaguer-Gargallo M, Rives-Solà S and Jordán-García I Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit. EUROPEAN JOURNAL OF PEDIATRICS . 181(3): 1037-1045.
- Mesegue-Meda M, Alonso-Saladrigues A, Pérez-Jaume S, Comes-Escoda A, José Luis Dapena Díaz, Faura A, Conde Cuevas N, Català-Temprano A, Ruiz-Llobet A, Zapico-Muñiz E, Camós-Guijosa M and Rives-Solà S Lower incidence of clinical allergy with PEG-asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG-ASP in pediatric patients with acute lymphoblastic leukemia. HEMATOLOGICAL ONCOLOGY . 39(5): 687-696.